3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
22
Neoplasms
16
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lung Neoplasms
7
Lymphoma
6
Hematologic Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Multiple Myeloma
5
Glioblastoma
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Interventions
Microscopy, Confocal
2
Indocyanine Green
2
Everolimus
2
varlilumab
1
Ultrasonography
1
Sunitinib
1
Simvastatin
1
Radiosurgery
1
Palliative Care
1
Neoadjuvant Therapy
1
Narrow Band Imaging
1
Interferon alpha-2
1
IFL protocol
1
Gastrectomy
1
Folfox protocol
1
Endoscopic Mucosal Resection
1
Drug Delivery Systems
1
Drug Combinations
1
Dermoscopy
1
Chemoradiotherapy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Margins of Excision
×
Palliative Care
×
Clear all
NCT07590726
2026-05-19
PIRe
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
160 enrolled